Sunshine Biopharma Inc (NASDAQ: SBFM) closed the day trading at $0.10 down -5.10% from the previous closing price of $0.10. In other words, the price has decreased by -$0.0052 from its previous closing price. On the day, 7369300 shares were traded.
Ratios:
For a better understanding of SBFM, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.45 and its Current Ratio is at 4.48. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.03.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 04 ’24 when Slilaty Steve N. bought 100,000 shares for $0.10 per share. The transaction valued at 10,000 led to the insider holds 130,000 shares of the business.
Slilaty Steve N. bought 20,000 shares of SBFM for $2,000 on Feb 08 ’24. The Chief Executive Officer now owns 30,000 shares after completing the transaction at $0.10 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SBFM now has a Market Capitalization of 9.39M and an Enterprise Value of -6.24M. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.40 while its Price-to-Book (P/B) ratio in mrq is 0.13. Its current Enterprise Value per Revenue stands at -0.26 whereas that against EBITDA is 1.63.
Stock Price History:
Over the past 52 weeks, SBFM has reached a high of $1.40, while it has fallen to a 52-week low of $0.04. The 50-Day Moving Average of the stock is 0.1063, while the 200-Day Moving Average is calculated to be 0.2955.
Shares Statistics:
Over the past 3-months, SBFM traded about 22.51M shares per day on average, while over the past 10 days, SBFM traded about 44.72M shares per day. A total of 99.45M shares are outstanding, with a floating share count of 91.94M. Insiders hold about 7.55% of the company’s shares, while institutions hold 11.83% stake in the company. Shares short for SBFM as of Mar 15, 2024 were 970.97k with a Short Ratio of 0.04, compared to 602.57k on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 0.98% and a Short% of Float of 1.02%.
Earnings Estimates
Current recommendations for the stock of the company come from 1 analysts. The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.
Analysts are recommending an EPS of between $0.09 and $0.09 for the fiscal current year, implying an average EPS of $0.09. EPS for the following year is $0.53, with 1 analysts recommending between $0.53 and $0.53.
Revenue Estimates
A total of 1 analysts have provided revenue estimates for SBFM’s current fiscal year. The highest revenue estimate was $44.4M, while the lowest revenue estimate was $44.4M, resulting in an average revenue estimate of $44.4M. In the same quarter a year ago, actual revenue was $24.09M, up 84.30% from the average estimate. Based on 1 analysts’ estimates, the company’s revenue will be $100M in the next fiscal year. The high estimate is $100M and the low estimate is $100M. The average revenue growth estimate for next year is up 125.20% from the average revenue estimate for this year.
